Home » Authors » Brady Huggett

Articles by Brady Huggett

Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner

Feb. 25, 2003

By Brady Huggett

Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner

Feb. 25, 2003

By Brady Huggett

BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme

Feb. 24, 2003

By Brady Huggett

BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme

Feb. 24, 2003

By Brady Huggett

Biogen's Amevive Shot Down In Europe; Approval Years Away

Feb. 21, 2003

By Brady Huggett

SomaLogic Raises $19.5M To Develop Proteomics Products

Feb. 21, 2003

By Brady Huggett

Biogen's Amevive Shot Down In Europe; Approval Years Away

Feb. 21, 2003

By Brady Huggett

SomaLogic Raises $19.5M To Develop Proteomics Products

Feb. 21, 2003

By Brady Huggett

BattellePharma Raises $22M To Develop Inhalation Program

Feb. 20, 2003

By Brady Huggett

BattellePharma Raises $22M To Develop Inhalation Program

Feb. 20, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...